Regeneron Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR TREATING PAIN IN SUBJECTS WITH RHEUMATOID ARTHRITIS

Last updated:

Abstract:

The present disclosure relates to the use of an anti-IL6 receptor antibody for treating unacceptable pain in subjects with rheumatoid arthritis. Subjects with unacceptable pain can have, e.g., refractory pain or strict refractory pain.

Status:
Application
Type:

Utility

Filling date:

3 Jun 2020

Issue date:

24 Dec 2020